Elena Post, M.S.,CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2974 E Main Rd, Portsmouth, RI 02871 Phone: 401-293-5790 |
Dahlia Siff Kalvinek, MS SSS-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2974 E Main Rd, Portsmouth, RI 02871 Phone: 401-293-5790 |
Erin Elizabeth Aleicho, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 48 Canonchet Dr, Portsmouth, RI 02871 Phone: 401-662-0090 |
Mrs. Debra M Smith, M.S. Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 38 W Passage Dr, Portsmouth, RI 02871 Phone: 401-683-0334 |
Ms. Elizabeth Hird Morley, M.S.,CCC Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 114 Col Christopher Greene Rd, Portsmouth, RI 02871 Phone: 401-849-6745 |
Mrs. Stephanie Elisabeth Conrad Kelley, M.S. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 11 King Charles Dr Ste A2, Portsmouth, RI 02871 Phone: 401-267-8757 Fax: 401-221-4242 |
Abby Noel Oresman Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 53 Tallman Ave, Portsmouth, RI 02871 Phone: 401-499-4636 |
Simply Speech Llc Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 11 King Charles Dr Ste A2, Portsmouth, RI 02871 Phone: 401-378-4449 Fax: 833-354-6737 |
Stephanie Marcellus, MS, CCC-SLP/L Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2974 E Main Rd, Portsmouth, RI 02871 Phone: 401-293-5790 |
News Archive
Aptus Endosystems Inc., a medical device company developing advanced technology for endovascular aneurysm repair (EVAR), announced that several patients with aortic aneurysm disease have been successfully treated with the Aptus EndoStapling System in Europe. The innovative helical staple technology enables independent endograft fixation, and is designed to approximate suturing in an open surgical anastomosis. The company continues to build on its U.S. clinical experience which includes 176 patients and deployment of more than 900 EndoStaples.
BG Medicine, Inc., a U.S. based, privately-held biomarker discovery and in vitro diagnostics company, announced today that there will be several data presentations regarding galectin-3 at the Heart Failure Congress 2010, the annual scientific meeting of the Heart Failure Association of the European Society of Cardiology, to be held in Berlin, Germany, on May 29th through June 1st. BG Medicine has developed and applied for FDA clearance of an in vitro diagnostic test to measure galectin-3 levels in plasma or serum.
A 21 percent reduction in Medicare reimbursements that has loomed over physicians all year will go into effect on June 1, unless Congress acts to further delay the cuts, CNNMoney reports. "If the proposed cuts go through, physicians are worried their practices will be so strapped that they'll have to drop some of the 43 million Americans who are covered under Medicare."
Ostomy patients using a new type of skin barrier product-infused with ceramides that play an essential role in the normal barrier function of the skin-experience lower costs of care, according to a randomized trial published in the Journal of Wound, Ostomy and Continence Nursing, the official journal of the Wound, Ostomy and Continence Nurses Society. The journal is published by Wolters Kluwer.
At the annual meeting of the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) on 30 June 2015, the Senate of the largest research funding organisation approved recommendations for "Developing Clinical Research at German Universities Between 2015 and 2025" (available in German).
› Verified 1 days ago